Literature DB >> 11797846

Choosing new adsorbents for endogenous ultrapure infusion fluid: performances, safety and flow distribution.

C De Nitti1, R Giordano, R Gervasio, G Castellano, V Podio, L Sereni, P M Ghezzi, C Ronco, A Brendolan, P Inguaggiato, M Tonelli, G La Greca, C Tetta.   

Abstract

Adsorption may notably contribute to the removal of uremic toxins and to the efficiency of hemodialysis. We examined different uncoated stationary matrixes, charcoals and synthetic resins to establish their adsorptive capacities in relation to low (urea, creatinine) and high molecular weight (beta2-microglobulin, myoglobin) compounds in in vitro conditions (steady state and flow-through) using isotonic solutions or uremic ultrafiltrate. Trace metal, particle release analyses and scanning electron microscopy of different adsorbents were performed. Dynamic flow-distribution studies were made using 99Technetium and analysing the different regions of interest by single head gamma-camera. We show that adsorbents may differ greatly as to their adsorptive capacity depending on flow rate, nature, and total mass of the compounds to be removed from the ultrafiltrate. These studies suggest a methodological approach for screening stationary matrixes for possible application in hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797846

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  6 in total

1.  Proteomic analisys of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes.

Authors:  Emanuela Monari; Monari Emanuela; Aurora Cuoghi; Cuoghi Aurora; Elisa Bellei; Bellei Elisa; Stefania Bergamini; Bergamini Stefania; Marialuisa Caiazzo; Caiazzo Marialuisa; Filippo Aucella; Aucella Filippo; Carmelo Loschiavo; Loschiavo Carmelo; Luca Corazza; Corazza Luca; Giuseppe Palladino; Palladino Giuseppe; Luisa Sereni; Sereni Luisa; Mauro Atti; Atti Mauro; Aldo Tomasi; Tomasi Aldo
Journal:  J Mater Sci Mater Med       Date:  2014-07-30       Impact factor: 3.896

2.  A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR).

Authors:  Sonia Pasquali; Francesco Iannuzzella; Mattia Corradini; Silvia Mattei; Achiropita Bovino; Alfredo Stefani; Giuseppe Palladino; Marialuisa Caiazzo
Journal:  J Nephrol       Date:  2014-08-23       Impact factor: 3.902

Review 3.  The implications and management of septic acute kidney injury.

Authors:  Zaccaria Ricci; Andrea Polito; Angelo Polito; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

4.  Efficacy of Supra-HFR in Removing FGF23 and Cytokines: A Single Session Analysis.

Authors:  Gabriele Donati; Andrea Angeletti; Maria Cappuccilli; Chiara Donadei; Chiara Guglielmo; Anna Scrivo; Lorenzo Gasperoni; Maddalena Zambelli; Maria Mattiotti; Gaetano La Manna
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

5.  Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients?

Authors:  Eleonora Riccio; Mauro Cataldi; Maristella Minco; Gennaro Argentino; Roberta Russo; Stefania Brancaccio; Andrea Memoli; Lucia Grumetto; Loredana Postiglione; Bruna Guida; Bruno Memoli
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

6.  Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra.

Authors:  Simonetta Palleschi; Paolo M Ghezzi; Giuseppe Palladino; Barbara Rossi; Marino Ganadu; Domenica Casu; Maria Cossu; Giovanni Mattana; Antonio Maria Pinna; Bruno Contu; Tonina Ghisu; Alessandro Monni; Luana Gazzanelli; Maria Cristina Mereu; Franco Logias; Mario Passaghe; Alessandro Amore; Piergiorgio Bolasco
Journal:  BMC Nephrol       Date:  2016-08-26       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.